Biocon Limited (Symbol:532523) SWOT Analysis, Strategy, Revenues and Profits

• Publication date: August 2011

Biocon Limited (Biocon) is a fully integrated healthcare company engaged in the manufacturing of biopharmaceutical products through using fermentation-based technology. The company produces wide range of active pharmaceutical ingredients (APIs), branded formulations and biologicals. Its core therapeutic areas include anti-diabetic, cardiovascular, anti-inflammatory, anti-obesity, hemostatic, hepatoprotective, gastro-intestinal, neutraceut...

Biocon Limited (Biocon) is a fully integrated healthcare company engaged in the manufacturing of biopharmaceutical products through using fermentation-based technology. The company produces wide range of active pharmaceutical ingredients (APIs), branded formulations and biologicals. Its core therapeutic areas include anti-diabetic, cardiovascular, anti-inflammatory, anti-obesity, hemostatic, hepatoprotective, gastro-intestinal, neutraceuticals, digestive-aid enzymes, immunosuppressants and anti-oxidants. In addition, the company provides contract manufacturing and research services in various fields such as mammalian and microbial cell culture fermentation; formulation development; synthetic chemistry; and vials to biotechnology and pharmaceutical companies. Biocon operates across the world through its subsidiaries and joint ventures. The company is headquartered in Bangalore, India

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

Biocon Limited SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about Biocon Limited operations to identify potential customers, partners and suppliers. Biocon Limited business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Latest Company Developments:

Biopharmaceutical Industry in India

I - Biocon Limited Company Profile

Key Information
Overview
Key Employees and biographies
Operational Heads
Main Products and Services
Historical Data
Company Mission Statement
Operations And Subsidiaries
Headquarter

II - Biocon Limited Company Analysis

Business Description
Company Vision and Strategy
SWOT Analysis
Strengths, Weaknesses, Opportunities, Threats
Competitive Landscape

III - Biocon Limited Financial Analysis and Performance Charts

Financial Ratios
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios

Biopharmaceutical in India

India Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Biopharmaceutical
• Countries : India

India Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Inrmn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Biopharmaceutical
• Countries : India

India Pharmaceutical Imports - Blood, Antisera, Vaccines, Toxins And Cultures, Inrmn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Biopharmaceutical
• Countries : India

India Pharmaceutical Imports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Biopharmaceutical
• Countries : India